Effects of curcumin on pentylenetetrazole-induced anxiety-like behaviors and associated changes in cognition and monoamine levels

Psychology and Neuroscience

Volumn 3, Issue 2, 2010, Pages

  Chimakurthy, Jithendra ^a   Talasila, Murthy ^a  

^a BAPATLA COLLEGE OF PHARMACY   (India)

Author keywords

Anxiety; Curcumin; Dopamine; Memory; Norepinephrine; Serotonin

Indexed keywords

ARACHIS OIL; BRAIN MONOAMINE; CATECHOLAMINE; CURCUMIN; DIAZEPAM; DOPAMINE; INDOLEAMINE; NEUROTRANSMITTER; NORADRENALIN; PENTETRAZOLE; SEROTONIN; SEROTONIN 1 AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; BLOOD LEVEL; BRAIN HOMOGENATE; CEREBELLUM; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; ELEVATED PLUS MAZE; EXPERIMENTAL TEST; HIPPOCAMPUS; HISTOPATHOLOGY; HYPOTHALAMUS; LATENT PERIOD; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MOOD DISORDER; NEUROLOGIC EXAMINATION; NONHUMAN; PASSIVE AVOIDANCE; PONS; RAT; TRANQUILIZING ACTIVITY;

EID: 78651451147     PISSN: 19843054     EISSN: 19833288     Source Type: Journal    
DOI: 10.3922/j.psns.2010.2.xxx     Document Type: Article

References (25)

1. American Psychiatric Association (2001). SSRI's show promise as treatment for anxiety disorders in children. Psychiatric News, 36 (10), 14.
2. Aalto, S., Brück, A., Laine, M., Någren, K., & Rinne, J.O. (2005). Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. Journal of Neuroscience, 25, 2471-2477.
3. Cassano, G.B., Pini, S., Saettoni, M., & Dell'Osso, L. (1999). Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features. American Journal of Psychiatry, 156, 474-476.
4. Clayton, E.C., & Williams, C.L. (2000). Adrenergic activation of the nucleus tractus solitarius potentiates amygdala norepinephrine release and enhances retention performance in emotionally arousing and spatial memory tasks. Behavioural Brain Research, 112, 151-158.
5. Coull, J.T. (1994). Pharmacological manipulations of the α2-noradrenergic system: effects on cognition. Drugs and Aging, 5, 116-126.
6. Dazzi, L., Seu, E., Cherchi, G., & Biggio, G. (2005). Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress. European Neuropsychopharmacology, 15, 283-290.
7. El Mansari, M., & Blier, P. (2006). Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder. Progress in Neuropsychopharmacology and Biological Psychiatry, 30, 362-373.
8. Eysenck, M.W., & Calvo, M.G. (1992). Anxiety and performance: the processing efficiency theory. Cognition and Emotion, 6, 409-434.
9. Ferry, B., Roozendaal, B., & McGaugh, J.L. (1999). Role of norepinephrine in mediating stress hormone regulation of long-term memory storage: a critical involvement of the amygdala. Biological Psychiatry, 46,1140-1152.
10. Goddard, A.W., Mason, G.F., Almai, A., Rothman, D.L., Behar, K.L., Petroff, O.A., Charney, D.S. & Krystal, J.H. (2001). Reductions in occipital cortex GABA levels in panic disorder detected with 1H-magnetic resonance spectroscopy. Archives of General Psychiatry, 58, 556-561.
11. Hobbs, W.R., Rall, T.W., & Verdoorn, T. (1996). Hypnotics and sedatives: ethanol. In J.G. Hardman & L.E. Limbird (Eds.), Goodman and Gillman's The Pharmacological Basis of Therapeutics, (9th ed., pp. 364-367). New York: McGraw-Hill.
12. Kari, H.P., Davidson, P.P., Kohl, H.H., & Kochhar, M.M. (1978). Effects of ketamine on brain monoamine levels in rats. Research Communications in Chemical Pathology and Pharmacology, 20, 475-488.
13. Ninan, P.T. (1999). The functional anatomy, neurochemistry, and pharmacology of anxiety. Journal of Clinical Psychiatry, 60 (Suppl 22), 12-17.
14. Nutt, D.J. (1998). Antidepressants in panic disorder: clinical and preclinical mechanisms. Journal of Clinical Psychiatry, 59 (Suppl 8), 24-28.
15. Nutt, D.J., Forshall, S., Bell, C., Rich, A., Sandford, J., Nash, J., & Argyropoulos, S. (1999). Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. European Neuropsychopharmacology, 9 (Suppl 3), S81-S86.
16. Pellow, S., Chopin, P., File, S.E., & Briley, M. (1985). Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14, 149-167.
17. Ravindran, R., Rathinasamy, S.D., Samson, J., & Senthilvelan, M. (2005). Noise-stressinduced brain neurotransmitter changes and the effect of Ocimum sanctum (Linn) treatment in albino rats. Journal of Pharmacological Sciences, 98, 354-360.
18. Ringman, J.M., Frautschy, S.A., Cole, G.M., Masterman, D.L., & Cummings, J.L. (2005). A potential role of the curry spice curcumin in Alzheimer's disease. Current Alzheimer Research, 2, 131-136.
19. Roozendaal, B. (2002). Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiology of Learning and Memory, 78, 578-595.
20. Satyan, K.S., Rai, A., Jaiswal, A.K., Acharya, S.B., & Bhattacharya, S.K. (1995). Isatin, a putative anxiogenic endocoid, induces memory dysfunction in rats. Indian Journal of Experimental Biology, 33, 576-579.
21. Sharma, P.C., Yelne, M.B., Dennis, T.J., Joshi, A., & Billore, K.V. (2002). Database on medicinal plants used in ayurveda. New Delhi: Central Council for Research in Ayurveda and Siddha.
22. Wesolowska, A., & Nikiforuk, A. (2007). Effects of the brain-penetrant and selective 5- HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology, 52, 1274-1283.
23. Xia, X., Cheng, G., Pan, Y., Xia, Z.H., & Kong, L.D. (2007). Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test. Journal of Ethnopharmacology, 110, 356-363.
24. Xu, Y., Ku, B.S., Yao, H.Y., Lin, Y.H., Ma, X., Zhang, Y.H. & Li, X.J. (2005). Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacology Biochemistry and Behavior, 82, 200-206.
25. Yu, Z.F., Kong, L.D., & Chen, Y. (2002). Antidepressant activity of aqueous extracts of Curcuma longa in mice. Journal of Ethnopharmacology, 83 (1-2), 161-165.